Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Redazione 4 Febbraio 2021 ...
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease Redazione 28 Gennaio 2021 ...
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial Redazione 28 Gennaio 2021 ...
A rationale to prioritise vaccination of HSCT patients against COVID-19 Redazione 28 Gennaio 2021 ...
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome Redazione 28 Gennaio 2021 ...
A brief rituximab, bendamustine, mitoxantrone (R‐BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL) Redazione 28 Gennaio 2021 ...
Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden Redazione 28 Gennaio 2021 ...
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial Redazione 28 Gennaio 2021 ...